1. Home
  2. PHUN vs VIGL Comparison

PHUN vs VIGL Comparison

Compare PHUN & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHUN
  • VIGL
  • Stock Information
  • Founded
  • PHUN 2009
  • VIGL 2020
  • Country
  • PHUN United States
  • VIGL United States
  • Employees
  • PHUN N/A
  • VIGL N/A
  • Industry
  • PHUN EDP Services
  • VIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • PHUN Technology
  • VIGL Health Care
  • Exchange
  • PHUN Nasdaq
  • VIGL Nasdaq
  • Market Cap
  • PHUN 88.8M
  • VIGL 89.3M
  • IPO Year
  • PHUN N/A
  • VIGL 2022
  • Fundamental
  • Price
  • PHUN $3.79
  • VIGL $2.64
  • Analyst Decision
  • PHUN Strong Buy
  • VIGL Strong Buy
  • Analyst Count
  • PHUN 3
  • VIGL 5
  • Target Price
  • PHUN $13.00
  • VIGL $21.00
  • AVG Volume (30 Days)
  • PHUN 1.5M
  • VIGL 2.6M
  • Earning Date
  • PHUN 03-11-2025
  • VIGL 03-25-2025
  • Dividend Yield
  • PHUN N/A
  • VIGL N/A
  • EPS Growth
  • PHUN N/A
  • VIGL N/A
  • EPS
  • PHUN N/A
  • VIGL N/A
  • Revenue
  • PHUN $3,537,000.00
  • VIGL N/A
  • Revenue This Year
  • PHUN N/A
  • VIGL N/A
  • Revenue Next Year
  • PHUN $93.33
  • VIGL N/A
  • P/E Ratio
  • PHUN N/A
  • VIGL N/A
  • Revenue Growth
  • PHUN N/A
  • VIGL N/A
  • 52 Week Low
  • PHUN $2.85
  • VIGL $1.49
  • 52 Week High
  • PHUN $18.45
  • VIGL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • PHUN 38.74
  • VIGL 71.47
  • Support Level
  • PHUN $3.71
  • VIGL $2.22
  • Resistance Level
  • PHUN $4.04
  • VIGL $2.53
  • Average True Range (ATR)
  • PHUN 0.27
  • VIGL 0.29
  • MACD
  • PHUN -0.06
  • VIGL 0.08
  • Stochastic Oscillator
  • PHUN 14.28
  • VIGL 80.47

About PHUN Phunware Inc.

Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States.

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.

Share on Social Networks: